Skip to main content

Closed

VCYT: Veracyte, Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Strong

Revenue growth+23.5% / yr

Operating margin17.0%

ROIC6.6%

Financially safe

Stretched

Debt / equity0.03×

Interest coverage0.0×

Current ratio9.16×

Valuation

Unrated

P/E ratio32.2×

Veracyte, Inc.

VCYTNASDAQ·USD·Closed

Veracyte, Inc.

VCYTNASDAQ·USD·Closed

$46.32

−22.52%

$46.32

−$13.46 (22.52%)

52W Range

62thpctl

Volume

4.52×avg

Mkt Cap

3.70BUSD

P/E

32.2TTM

Div Yield

–ann

52W Range

62thpctl

Volume

4.52×avg

Market Cap

3.70BUSD

P/E Ratio

32.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings